|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| CURRENT ASSETS: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable—net | ||||||||||||||||||||
| Contract revenues in excess of billings | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| PROPERTY AND EQUIPMENT—Net | ||||||||||||||||||||
| OPERATING LEASE ASSETS | ||||||||||||||||||||
| GOODWILL | ||||||||||||||||||||
| INVENTORIES—Noncurrent | ||||||||||||||||||||
| OTHER | ||||||||||||||||||||
| TOTAL | ||||||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Billings in excess of contract revenues | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| LONG-TERM DEBT | ||||||||||||||||||||
| REVOLVING CREDIT FACILITY | ||||||||||||||||||||
| LONG-TERM DEBT - REVOLVER | ||||||||||||||||||||
| OPERATING LEASE LIABILITIES—Noncurrent | ||||||||||||||||||||
| DEFERRED INCOME TAXES | ||||||||||||||||||||
| OTHER | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| EQUITY: | ||||||||||||||||||||
| Common stock - $.0001 par value; 170,000 shares authorized, 68,087 and 67,280 shares issued at December 31, 2025 and December 31, 2024, respectively, and 66,775 and 67,280 shares outstanding at December 31, 2025 and December 31, 2024, respectively. | ||||||||||||||||||||
| Treasury stock; 1,312 and zero shares at December 31, 2025 and December 31, 2024, respectively. | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| TOTAL |
Loading...